Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Related Party Transactions_March 31, 2022
May 26, 2022
Newspaper Publication_Audited Financial Results_March 31, 2022
May 16, 2022
Outcome of Board Meeting_May 12, 2022
May 12, 2022
Intimation of Board Meeting_May 12, 2022
May 5, 2022
Initial disclosure regarding large corporate_2022
April 26, 2022
Corporate Governance Report_March 31, 2022
April 25, 2022
Certificate under Regulation 40(9)_March 31, 2022
April 25, 2022
Reconciliation of Share Capital Audit Report_March 31, 2022
April 25, 2022
Statement of Investor Complaints_March 31, 2022
April 20, 2022
Certificate under Reg 7(3) SEBI (LODR)_March 31, 2022
April 11, 2022
Intimation - Three Star Export House recognition
April 7, 2022
Certificate under Regulation 74(5)_March 31, 2022
April 5, 2022
Notice of Closure of Trading Window_March 31, 2022
March 31, 2022
Scheme of Amalgamation - No Objection Letters from NSE and BSE
March 30, 2022
Incorporation of a Wholly Owned Subsidiary_March 2022
March 24, 2022
Disbursement on Fractional Shares pursuant to reduction and consolidation of share capital
March 16, 2022
Previous
1
...
Next
17 / 36